{"abstract": "A campaign for the drug maker Novartis uses the slogan \u201cHey MS, Take This!\u201d and shows patients sticking out their tongues with capsules on them in defiance of the disease.", "web_url": "https://www.nytimes.com/2013/04/04/business/media/an-ms-drug-takes-a-feisty-approach-aimed-at-younger-patients.html", "snippet": "A campaign for the drug maker Novartis uses the slogan \u201cHey MS, Take This!\u201d and shows patients sticking out their tongues with capsules on them in defiance of the disease.", "lead_paragraph": "THE Swiss drug maker Novartis is taking a sassy new tack to win converts to its oral multiple sclerosis treatment, Gilenya. Its \u201cHey MS, Take This!\u201d campaign shows patients sticking out their tongues with Gilenya capsules on them to show their willingness to fight back against the neurological condition.", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/04/04/business/Adco/Adco-articleLarge.jpg", "height": 337, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2013/04/04/business/Adco/Adco-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 337}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/04/04/business/Adco/Adco-jumbo.jpg", "height": 575, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/04/04/business/Adco/Adco-superJumbo.jpg", "height": 1077, "width": 1919, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2013/04/04/business/Adco/Adco-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2013/04/04/business/Adco/Adco-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/04/04/business/Adco/Adco-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "An MS Drug Takes a Feisty Approach Aimed at Younger Patients", "kicker": "Advertising", "content_kicker": null, "print_headline": "An MS Drug Takes a Feisty Approach Aimed at Younger Patients", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "persons", "value": "Olson, Elizabeth", "rank": 2, "major": "N"}, {"name": "subject", "value": "ADVERTISING AND MARKETING", "rank": 3, "major": "N"}, {"name": "subject", "value": "Multiple Sclerosis", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 5, "major": "N"}], "pub_date": "2013-04-04T02:06:17+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "Media", "byline": {"original": "By Elizabeth Olson", "person": [{"firstname": "Elizabeth", "middlename": null, "lastname": "Olson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/169e0dd5-1a1b-5254-a23f-221c1eab562b", "word_count": 902, "uri": "nyt://article/169e0dd5-1a1b-5254-a23f-221c1eab562b"}